Rights and permissions
About this article
Cite this article
Cost analysis of antineoplastic-induced neutropenia. Pharmacoecon. Outcomes News 13, 10 (1994). https://doi.org/10.1007/BF03293614
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03293614